Swift, Certain, and Fair: Reducing Recidivism and Improving Outcomes for Alcohol and Drug Users on State Parole

March 7, 2019 updated by: Botec Analysis, LLC

This research project will study the outcomes of medium- to high-risk parolees with a history of substance abuse in Alleghany County, Pennsylvania supervised under Swift-Certain-Fair parole.

The research goals are to:

  • Determine the effectiveness of SCF parole in reducing recidivism among medium- to high-risk parolees with a history of substance abuse in Pennsylvania.
  • Determine the minimum effective sanction in response to a violation that will bring parolees into compliance with the conditions of their parole.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Assigned to the Pittsburgh District
  • Allegheny County resident
  • Has at least 2 years left on supervision
  • Had a prior drug or alcohol related sanction

Exclusion Criteria:

  • Sex offender
  • Reentrants assigned to the Special Needs Unit

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Experimental: Secure Confinement Group
Parolees assigned to this group will be assigned sanctions that include secure confinement.
Behavioral: SCF Supervision with Secure Confinement Sanctioning
Parolees assigned to this group will, in the face of a violation, be given a sanction that involves secure confinement.
Experimental: Work Release Group
Parolees assigned to this group will be assigned sanctions that include work-release.
Behavioral: SCF Supervision with Work Release Sanctioning
Parolees assigned to this group will, in the face of a violation, be given a sanction that involves work-release.
Experimental: GPS Supervision Group
Parolees assigned to this group will be assigned sanctions that include GPS supervision.
Behavioral: SCF Supervision with GPS Supervision Sanctioning
Parolees assigned to this group will, in the face of a violation, be given a sanction that involves GPS supervision.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Revocation Rate
Time Frame: 9 Months
Percentage of subjects in each condition who are revoked from parole and returned to prison
9 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Days Incarcerated
Time Frame: 9 Months
Total number of days incarcerated in jail or prison per parolee
9 Months
New Charges
Time Frame: 9 Months
Number of new charges per parolee
9 Months
Percent Positive Drug Tests
Time Frame: 9 Months
Percentage of random and scheduled drug tests that result in a positive reading for illicit drugs
9 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Botec Analysis, LLC

Collaborators

Pennsylvania Department of Corrections
Bureau of Justice Assistance

Investigators

  • Principal Investigator: Mark AR Kleiman, BOTEC Analysis

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

April 1, 2019

Primary Completion (Anticipated)

August 15, 2020

Study Completion (Anticipated)

December 31, 2020

Study Registration Dates

First Submitted

January 30, 2019

First Submitted That Met QC Criteria

January 30, 2019

First Posted (Actual)

February 1, 2019

Study Record Updates

Last Update Posted (Actual)

March 11, 2019

Last Update Submitted That Met QC Criteria

March 7, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BOTEC PADOC SCF

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance Abuse

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe